YNBY International Limited, an investment holding company, engages in the money lending, and trading of goods and commodities in Hong Kong, the People's Republic of China, and internationally. The company operates through Money Lending; Trading of Goods and Commodities; and Cannabidiol isolate segments. It provides short-term personal and corporate loans; and trades in refined edible oil, sugar, cosmetic, cannabidiol, and personal care products. YNBY International Limited has a strategic cooperation agreement with Alpex Pharma SA to cooperate on the development and commercialization of nutraceutical products. The company was formerly known as Ban Loong Holdings Limited and changed its name to YNBY International Limited in September 2023. YNBY International Limited is based in Wan Chai, Hong Kong.
Stock data | 2023 | Change |
---|---|---|
Price | $0.0100042582227307 | N/A |
Market Cap | $67.39M | N/A |
Shares Outstanding | 6.74B | 4.47% |
Employees | 43.00 | N/A |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -0.40 | N/A |
P/S Ratio | 1.16 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $58.09M | N/A |
Earnings | -$21.66M | N/A |
EPS | -0.0251 | N/A |
Earnings Yield | -2.51 | N/A |
Gross Margin | 0.0506 | N/A |
Operating Margin | -0.3528 | N/A |
Net income margin | -0.3728 | N/A |